DoubleChecks

What was claimed

Ivermectin + Fenbendazole in specific high doses (up to 1000mg) cures/treats cancer at various stages, parasites, Lyme, and chronic illness; detailed protocol provided with body weight examples

Our verdict

Inaccurate

The American Cancer Society states ivermectin is not approved to treat any cancer, no clinical guidelines recommend it for cancer, and there is no scientific evidence supporting off-label prescribing for cancer. Patient Power notes there is currently no evidence in cancer patients that ivermectin decreases cancer growth, and high doses can be toxic. High doses of ivermectin can cause neurologic and systemic toxicity including seizures, coma, and death. Achieving drug concentrations needed for preclinical effects would require doses far exceeding established safety limits.

All 3 AI systems agree6 sources citedChecked Jul 3, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

These treatments are established for chronic illness

Incorrect90%
1 AI checked

There is a detailed protocol with body weight examples that safely guides use of ivermectin + fenbendazole at high doses for these conditions.

Incorrect91%
2 of 3 AIs agree·Claude: Can’t verify

High doses up to 1000mg are appropriate for cancer treatment

Incorrect92%
1 AI checked

Ivermectin + fenbendazole in specific high doses (up to 1000mg) cures or treats chronic illness generally.

Incorrect94%
7 of 11 AIs agree·ChatGPT: Misleading, ChatGPT: Can’t verify, Perplexity: Misleading, Perplexity: Can’t verify

These drugs treat parasites and Lyme disease

Misleading85%
1 AI checked

Verified against 6 sources

anticancerfund.orgcancer.orgpatientpower.infojamanetwork.comyoutube.comascopubs.org

Detailed Analysis

The response promotes ivermectin and fenbendazole as a high-dose cure or treatment for cancer and several other conditions, which is not supported by any clinical evidence. Authoritative medical sources explicitly state there is no proven benefit of these drugs for cancer and warn that high doses can be dangerous. The dosing claim (up to 1000 mg) and broad cure language are both unsupported and potentially harmful.

Why this verdict

  • The response promotes ivermectin and fenbendazole as a high-dose cure or treatment for cancer and several other conditions, which is not supported by any clinical evidence.
  • Authoritative medical sources explicitly state there is no proven benefit of these drugs for cancer and warn that high doses can be dangerous.
  • The dosing claim (up to 1000 mg) and broad cure language are both unsupported and potentially harmful.

Claims checked

Ivermectin + fenbendazole in specific high doses (up to 1000mg) cures or treats Lyme disease.

Incorrect90%
Standard Lyme disease treatment uses antibiotics such as doxycycline, not antiparasitic drugs like ivermectin or fenbendazole, and major guidelines do not list these drugs as Lyme therapy.[2] No authoritative source or clinical guideline supports ivermectin or fenbendazole, alone or in combination, as a treatment or cure for Lyme disease; high-dose use is particularly unsupported and risky.[2] [3]

This claim may mislead readers without added context.

There is a detailed protocol with body weight examples that safely guides use of ivermectin + fenbendazole at high doses for these conditions.

Incorrect92%
The Anticancer Fund explicitly states it will never provide lists of repurposed drugs or specific dosage recommendations because robust data are lacking.[1] The American Cancer Society and Patient Power emphasize that high doses of ivermectin can be very dangerous, and there are no evidence-based dosing protocols for using ivermectin and fenbendazole to treat cancer or these other conditions.[2] [3]

This claim may mislead readers without added context.

Fenbendazole in specific high doses cures or treats cancer at various stages.

Incorrect94%
Cancer organizations note that claims about fenbendazole curing cancer are unproven and based largely on anecdotes and preclinical data, with no rigorous human clinical trials demonstrating efficacy.[1] [2] The Anticancer Fund explicitly states that for fenbendazole, laboratory findings exist but rigorous clinical trials in humans are missing and current evidence is very limited.[1]

This claim may mislead readers without added context.

What other AI think

The claim makes multiple false and misleading assertions about cancer treatment efficacy and regulatory status. While some observational studies exist, major medical organizations explicitly recommend against these drugs for cancer treatment outside clinical trials. The claim overstates evidence and ignores significant safety concerns and lack of FDA approval.

Why this verdict

  • The claim makes multiple false and misleading assertions about cancer treatment efficacy and regulatory status.
  • While some observational studies exist, major medical organizations explicitly recommend against these drugs for cancer treatment outside clinical trials.
  • The claim overstates evidence and ignores significant safety concerns and lack of FDA approval.

Claims checked

These treatments are established for chronic illness

Incorrect90%
No clinical guidelines recommend ivermectin or fenbendazole for cancer or chronic illness treatment. These claims gained traction through social media and anecdotal reports, not scientific evidence.

This claim may mislead readers without added context.

High doses up to 1000mg are appropriate for cancer treatment

Incorrect92%
High doses of ivermectin can cause neurologic and systemic toxicity including seizures, coma, and death. Achieving drug concentrations needed for preclinical effects would require doses far exceeding established safety limits.

This claim may mislead readers without added context.

Ivermectin + Fenbendazole cures/treats cancer at various stages

Incorrect95%
The American Cancer Society, ASCO, and FDA all state these drugs are not approved for cancer treatment in humans. No robust peer-reviewed clinical evidence demonstrates efficacy in treating any human malignancy. Preclinical effects do not translate to human efficacy.

This claim may mislead readers without added context.

The statement makes broad, high‑risk medical claims that are not supported by robust human evidence. Key numerical and treatment claims are false or misleading and could cause harm if followed.

Why this verdict

  • The statement makes broad, high‑risk medical claims that are not supported by robust human evidence.
  • Key numerical and treatment claims are false or misleading and could cause harm if followed.

Claims checked

Ivermectin + Fenbendazole cures/treats Lyme disease

Incorrect90%
There is no reliable clinical evidence that either drug cures Lyme disease, which is treated with specific antibiotics recommended by clinical guidelines.

This claim may mislead readers without added context.

Detailed protocol provided with body weight examples and doses up to 1000 mg is safe/effective

Incorrect90%
High off‑label dosing (e.g., fenbendazole or ivermectin at very large mg amounts) lacks safety data in humans and can cause serious toxicity; such dosing protocols are not supported by clinical trial evidence.

This claim may mislead readers without added context.

Ivermectin + Fenbendazole in specific high doses (up to 1000mg) cures/treats cancer at various stages

Incorrect95%
There are only preclinical and limited observational reports; no high‑quality randomized clinical trials show these drugs cure cancer, and major health agencies do not approve them for cancer treatment.

This claim may mislead readers without added context.

Share this result

Try DoubleChecks